APA (7th ed.) Citation

Bellitto, C., Luxi, N., Ciccimarra, F., L’Abbate, L., Raethke, M., van Hunsel, F., . . . Trifirò, G. (2024). What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study. Drug safety, 47(10), 1011-1023. https://doi.org/10.1007/s40264-024-01449-x

Chicago Style (17th ed.) Citation

Bellitto, Chiara, et al. "What Is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study." Drug Safety 47, no. 10 (2024): 1011-1023. https://doi.org/10.1007/s40264-024-01449-x.

MLA (9th ed.) Citation

Bellitto, Chiara, et al. "What Is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study." Drug Safety, vol. 47, no. 10, 2024, pp. 1011-1023, https://doi.org/10.1007/s40264-024-01449-x.